National Asset Management, Inc. Cocrystal Pharma, Inc. Transaction History

National Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.27 - $3.6 $0 - $3	1 Added 0.01%	12,727 $4,000
Q4 2020 Feb 04, 2021	SELL	$0.8 - $2.16 $0 - $2	-1 Reduced 0.01%	12,726 $18,000
Q3 2020 Nov 09, 2020	BUY	$0.86 - $2.36 $0 - $2	1 Added 0.01%	12,727 $12,000
Q1 2018 May 15, 2018	BUY	$3.9 - $6.9 $49,631 - $87,809	12,726 New	12,726 $76,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.